The number you never get to see
You hand over a prescription. A price appears on a screen turned halfway toward you. You pay it — or wince and pay it — and walk out. The whole exchange takes about a minute, and in that minute you make a financial decision with exactly one piece of information: the number they quoted. You have nothing to weigh it against, so you weigh it against itself. It becomes both the offer and the standard for judging the offer.
That is a strange way to spend money, and it isn't your fault. Almost nowhere else do we buy something without a rough sense of what it should cost. We know a gallon of milk is a few dollars and a plane ticket is hundreds; when a price strays far from that internal reference, an alarm goes off. At the pharmacy counter, the alarm never rings, because most of us have no reference at all. There is, however, a public number that could serve as one. It's called NADAC, and once you understand it, the counter never looks quite the same.
What NADAC actually is
NADAC stands for National Average Drug Acquisition Cost. It's a dataset published by the Centers for Medicare & Medicaid Services — the same federal agency that runs Medicare and Medicaid. Its purpose is narrow and specific: to estimate what retail pharmacies across the country actually pay to acquire the medications they dispense.
The number isn't guessed or modeled from list prices. It comes from a monthly survey that asks a broad sample of retail community pharmacies to report their real invoice costs — the prices they were charged by wholesalers for the drugs sitting on their shelves. CMS averages those invoices, drug by drug, and publishes the result per unit: per tablet, per milliliter, per gram. The file is refreshed weekly and rebuilt from a full survey each month. It is free, public, and downloadable by anyone.
In other words, NADAC is the closest thing that exists to an honest national answer to the question the counter never volunteers: what did this actually cost before anyone marked it up?
Acquisition cost is not the price you pay
Here is the distinction that makes the number useful. NADAC reflects the pharmacy's acquisition cost — what they paid the wholesaler. It does not include the pharmacy's overhead, the pharmacist's time, or profit. A legitimate cash price will always sit above NADAC, because a pharmacy is a business that has to keep the lights on.
The honest markup has a name too: the dispensing fee. It covers the labor and cost of counting, verifying, labeling, and handing you the medication, and for a typical generic it's usually a matter of a few dollars. So a fair cash price looks roughly like this: acquisition cost, plus a reasonable dispensing fee. Nothing exotic.
What this framing reveals is where the fairness lives — or doesn't. Many of the most commonly prescribed generic drugs have acquisition costs of just pennies per tablet. When the price you're quoted for a month's supply of one of those drugs is not a few dollars but many times that, the gap isn't the dispensing fee. It's something else, and NADAC is what lets you see the gap at all.
Why an outside number changes the whole decision
There's a well-documented reason a benchmark matters so much here, and it comes from behavioral science rather than pharmacy. Psychologists Amos Tversky and Daniel Kahneman described what they called anchoring: when we make a judgment under uncertainty, the first number we encounter exerts a gravitational pull on every estimate that follows. We adjust away from it, but never far enough. The anchor quietly sets the range of what feels reasonable.
At the counter, the quoted price is the anchor. With no competing figure, your mind treats it as the center of gravity — high, maybe, but plausibly the price. This is why two people can pay wildly different amounts for the identical generic and each walk away feeling they paid roughly what it costs. Each was anchored to their own receipt.
An external reference breaks the spell. The moment you carry a rough sense of acquisition cost into the transaction, the quoted number stops being judged against itself and starts being judged against a fixed point outside the store. A price that looked like the price suddenly looks like a price — one option among several, and possibly a poor one. Nothing about the drug changed. Your reference point did, and that's often enough to change what you do next.
How to read the number without a spreadsheet
You don't need to become an analyst to use this. The mental model is short.
Start with the per-unit figure, because that's how NADAC is published. Multiply it by the quantity in your prescription — say, the number of tablets in a 30-day fill. That gives you the approximate acquisition cost of the whole fill. Then add a few dollars for a reasonable dispensing fee. What you're left with is a defensible estimate of what a fair cash price would be.
Hold that estimate up against the number on the screen. If they're in the same neighborhood, you're being treated fairly and you can stop thinking about it. If the counter price towers over your estimate, you've learned something the pharmacy had no incentive to tell you — and you now have a concrete reason to ask whether there's a lower cash price, or to call another pharmacy before you commit.
The honest limits of the benchmark
NADAC is a reference, not a quote, and it's worth respecting what it can't do. It's a national average, so real acquisition costs vary by region and by the deal a particular pharmacy struck with its wholesaler. It lags real time slightly, since it's built from surveys. It deliberately excludes the dispensing fee, which is why you add one back yourself. And for brand-name drugs, or generics that have only recently lost patent protection and are still settling, prices can move faster than a monthly average can track.
None of that undermines the point. A benchmark doesn't have to be a perfect prediction of your exact receipt. It only has to be an independent, trustworthy reference — a fixed star you can steer by. Even an approximate outside number is transformative when the alternative is a single figure with nothing behind it. The counter's whole advantage rests on your having no other point of comparison. NADAC quietly removes that advantage.
What it feels like to walk in already knowing
The practical shift is smaller than you'd expect and larger than it sounds. You're not memorizing a database or arguing with a pharmacist. You're simply arriving with a rough idea of what fair looks like, so that the number on the screen has to answer to something. Most of the time it will pass, and you'll pay with a little more peace of mind. Sometimes it won't, and knowing that — before you've handed over a card — is the entire game. The people who overpay for prescriptions aren't careless. They're just anchored, because no one ever gave them a second number.
That second number is exactly what SnapRx is built to hand you. Snap a photo of your prescription label and it pulls the CMS NADAC benchmark for that drug, translates the per-unit acquisition cost into a fair-price estimate for your fill, and shows you real pharmacies nearby to call — so the counter's quote is no longer the only figure in the room. It doesn't argue on your behalf or promise a magic discount. It just makes sure you know the typical number before you fill, the way you'd want to for anything else you buy.
If you'd like to walk in with the reference price already in your pocket, you can try it at snaprx.lumenlabs.works.